Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Hemodialysis Market" report has been added to ResearchAndMarkets.com's offering.
The global hemodialysis market, valued at USD 80.26 billion in 2023, is projected to ascend to USD 122.51 billion by 2034, expanding at a compound annual growth rate (CAGR) of 3.92% within the period of 2024-2034. The market is propelled by increasing instances of chronic kidney disease (CKD), coupled with significant strides in technology, and a heightened awareness concerning diagnosis and treatment.
Technological innovations have been pivotal in refining patient outcomes, efficiency, and safety in the realm of hemodialysis. Advanced hemodialysis machines, sophisticated filtering technologies, and enhanced monitoring devices have been integral in this progress. These advancements align with healthcare providers' efforts to ameliorate care facilities which, in turn, contribute to market growth. Notable agreements, such as the one between key industry players to develop AI-driven personalized dialysis care solutions, mark the forward momentum of the industry.
Market Segmentation:
- The equipment segment holds a significant share, backed by burgeoning demand for state-of-the-art dialysis machines and monitoring devices.
- Consumable components are projected to exhibit the highest growth rate, emphasizing the call for cost-effective and efficient disposable supplies.
- Conventional long-term hemodialysis remains the dominant modality, although short daily hemodialysis is picking up speed with its promise of improved patient quality of life.
- Hospitals are the main end-users, given their comprehensive facilities, although home care is anticipated to surge as patient preferences lean towards convenience and personalization.
Regional Insights:
- The North American market is expected to maintain a substantial revenue share, attributed to its robust healthcare systems and high incidence of CKD.
- The Asia Pacific region is forecasted to witness the most accelerated growth, thanks to an expanding patient demographic, increased healthcare awareness, and rising income levels.
Market Forecast by Region:
- North America: The market in the United States and Canada continues to benefit from advanced healthcare infrastructure and impactful kidney disease awareness campaigns.
- Europe: Germany, France, the UK, and other European nations are experiencing a steady market progression, influenced by consolidating healthcare policies and a focus on renal care.
- Asia Pacific: As the fastest-growing region, countries like China, Japan, and India are transforming the landscape with enhancements in healthcare provisions and a surge in hemodialysis adoption.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value (USD) in 2023 | $80.26 Billion |
| Forecasted Market Value (USD) by 2034 | $122.51 Billion |
| Compound Annual Growth Rate | 3.9% |
| Regions Covered | Global |
Companies Mentioned
- Insilico Biotechnology AG
- Evidera (PAREXEL International Corporation)
- LeadInvent Technologies Pvt. Ltd.
- Physiomics plc
- INOSIM Software GmbH
- Genedata AG
- Rosa & Co. LLC
- Archimedes Development Ltd.
- Entelos
- Collaborative Drug Discovery Inc.
For more information about this report visit https://www.researchandmarkets.com/r/mhl7tc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
